Dec 1 (Reuters) - Neurosense Therapeutics Ltd NRSN.O :
* NEUROSENSE ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS
AND
PROVIDES BUSINESS UPDATE
* NEUROSENSE THERAPEUTICS LTD - AS OF SEPTEMBER 30, 2022,
NEUROSENSE HAD CASH AND SHORT-TERM DEPOSITS OF $8.44 MILLION
* NEUROSENSE THERAPEUTICS LTD - BELIEVES THAT CASH RESOURCES
WILL
BE SUFFICIENT TO CONTINUE DEVELOPMENT OF CO'S PRODUCT INTO Q4 OF
2023
* NEUROSENSE THERAPEUTICS LTD - QTRLY LOSS PER SHARE $0.80
Source text for Eikon: ID:nPnZz2pKa
Further company coverage: NRSN.O
((Reuters.Briefs@thomsonreuters.com;;))